Arena Pharmaceuticals, (ARNA) Posts Wider than Expected Q4 Loss of 16c/Share

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q4 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $3.49 million.

For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• CrowdStrike shares jump on earnings beat, raised outlook
• Agilent Technologies (A) Tops Q3 EPS by 13c, Beats on Revenue; Offers FY EPS Guidance
• Urban Outfitters (URBN) Misses Q2 EPS by 1c